These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 19686207)
21. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study. Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133 [TBL] [Abstract][Full Text] [Related]
22. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study. Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639 [TBL] [Abstract][Full Text] [Related]
23. Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome. Sliger M; Lander T; Murphy C J Alzheimers Dis; 2004 Aug; 6(4):397-402; discussion 443-9. PubMed ID: 15345810 [TBL] [Abstract][Full Text] [Related]
24. Differential Aging Trajectories of Modulation of Activation to Cognitive Challenge in APOE ε4 Groups: Reduced Modulation Predicts Poorer Cognitive Performance. Foster CM; Kennedy KM; Rodrigue KM J Neurosci; 2017 Jul; 37(29):6894-6901. PubMed ID: 28652414 [TBL] [Abstract][Full Text] [Related]
25. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Bacon AW; Bondi MW; Salmon DP; Murphy C Ann N Y Acad Sci; 1998 Nov; 855():723-31. PubMed ID: 9929677 [TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
27. Strategy or symptom: Semantic clustering and risk of Alzheimer's disease-related impairment. Ford J; Zheng B; Hurtado B; de Jager CA; Udeh-Momoh C; Middleton L; Price G J Clin Exp Neuropsychol; 2020 Oct; 42(8):849-856. PubMed ID: 32933358 [TBL] [Abstract][Full Text] [Related]
28. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging. Klages JD; Fisk JD; Rockwood K Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072 [TBL] [